Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group

Leukemia and Lymphoma

Volumn 44, Issue 11, 2003, Pages 1903-1910

  Huang, James Z ^a,c   Weisenburger, Dennis D ^a   Vose, Julie M ^a   Greiner, Timothy C ^a   Aoun, Patricia ^a   Chan, Wing C ^a   Lynch, James C ^b   Bierman, Philip J ^a   Armitage, James O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Diffuse large B cell lymphoma; Nodular lymphocyte predominant Hodgkin lymphoma; Non Hodgkin's lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B CELL LYMPHOMA; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SEX RATIO; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; NEBRASKA; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; SURVIVAL RATE;

EID: 0242467357     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000123528     Document Type: Article

References (40)

1. Poppema, S. (1992) "Lymphocyte-predominance Hodgkin's disease", Semin. Diagn. Pathol. 9, 257-264.
2. Chan, W.C. (1999) "Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies", Semin. Hematol. 36, 242-252.
3. Pappa, V.I., Norton, A.J., Gupta, R.K., Wilson, A.M., Rohatiner, A.Z. and Lister, T.A. (1995) "Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases", Ann. Oncol. 6, 559-565.
4. Sextro, M., Diehl, V., Franklin, J., Hansmann, M.L., Anagnostopoulos, I., Marafioti, T. and Stein, H. (1996) "Lymphocyte predominant Hodgkin's disease - a workshop report. European Task Force on Lymphoma", Ann. Oncol. 7, 61-65.
5. Diehl, V., Sextro, M., Franklin, J., Hausmann, M.L., Harris, N., Jaffe, E., Poppema, S., Harris, M., Franssila, K., van Krieken, J., Marafioti, T., Anagnostopoulos, I. and Stein, H. (1999) "Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease", J. Clin. Oncol. 17, 776-783.
6. Ha, C.S., Kavadi, V., Dimopoulos, M.A., Hagemeister, F.B., Osborne, B.M., Fuller, L.M., Smith, T.L., Hess, M.A., McLaughlin, P.W., Cabanillas, F.F. and Cox, J.D. (1999) "Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria", Int. J. Radiat. Oncol. Biol. Phys. 43, 329-334.
7. Miettinen, M., Franssila, K.O. and Saxen, E. (1983) "Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas", Cancer 51, 2293-2300.
8. Hansmann, M.L., Zwingers, T., Boske, A., Loffler, H. and Lennert, K. (1984) "Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular)", J. Cancer Res. Clin. Oncol. 108, 321-330.
9. Toner, G.C., Sinclair, R.A., Sutherland, R.C. and Schwarz, M.A. (1986) "Composite lymphoma", Am. J. Clin. Pathol. 86, 375-378.
10. Sundeen, J.T., Cossman, J. and Jaffe, E.S. (1988) "Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy?", Am. J. Surg. Pathol. 12, 599-606.
11. Hansmann, M.L., Stein, H., Fellbaum, C., Hui, P.K., Parwaresch, M.R. and Lennert, K. (1989) "Nodular paragranuloma can transform into high-grade malignant lymphoma of B type", Hum. Pathol. 20, 1169-1175.
12. Grossman, D.M., Hanson, C.A. and Schnitzer, B. (1991) "Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma", Am. J. Surg. Pathol. 15, 668-676.
13. Jaffe, E.S., Zarate-Osorno, A., Kingma, D.W., Raffeld, M. and Medeiros, L.J. (1994) "The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas", Ann. Oncol. 5, 7-11.
14. Bennett, M.H., MacLennan, K.A., Vaughan Hudson, G., et al. (1991) "Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation", Ann. Oncol. 2(Suppl. 2), 83-92.
15. Wickert, R.S., Weisenburger, D.D., Tierens, A., Greiner, T.C. and Chan, W.C. (1995) "Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage", Blood 86, 2312-2320.
16. Hell, K., Hansmann, M.L., Pringle, J.H., Lauder, I. and Fischer, R. (1995) "Combination of Hodgkin's disease and diffuse large cell lymphoma: an in situ hybridization study for immunoglobulin light chain messenger RNA", Histopathology 27, 91-499.
17. Greiner, T.C., Gascoyne, R.D., Anderson, M.E., Kingma, D.W., Adomat, S.A., Said, J. and Jaffe, E.S. (1996) "Nodular lymphocyte-predominant Hodgkin's disease associated with large- cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction", Blood 88, 657-666.
18. Ohno, T., Huang, J.Z., Wu, G., Wu, G., Weisenburger, D.D. and Chan, W.C. (2001) "The tumor cells in nodular lymphocyte-predominant Hodgkin disease are clonally related to the large cell lymphoma occurring in the same individual. Direct demonstration by single cell analysis", Am. J. Clin. Pathol. 116, 506-511.
19. Kroft, S.H. (2001) "Lymphoma transformation: genetic relatedness, stealth lymphomas, and the final frontier", Am. J. Clin. Pathol. 116, 811-814.
20. Kim, H., Hendrickson, R. and Dorfman, R.F. (1977) "Composite lymphoma", Cancer 40, 959-976.
21. Whittaker, M., Fomcar, K., Keith, T. and McAneny, B. (1989) "Simultaneous nodular lymphocyte predominance Hodgkin's disease (N-LPHD) and large-cell lymphoma (LCL)", Am. J. Surg. Pathol. 13, 715-716.
22. The International Non-Hodgkin's Lymphoma Prognostic Factors Project(1993) "A predictive model for aggressive non-Hodgkin's lymphoma", N. Engl. J. Med. 32, 987-994.
23. Vose, J.M. (1995) "CHLVPP therapy for Hodgkin's disease identification of prognostic factors", Leak. Lymphoma 15(Suppl. 1), 13-14.
24. Pavlovsky, S., Santarefli, M.T., Erazo, A., Diaz Maqueo, J.C., Somoza, N., Lluesma Gonalons, M., Cervantes, G., Garcia Vela, E.L., Corrado, C. and Magnasco, H. (1992) "Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP", Ann. Oncol. 3, 205-209.
25. Andrieu, J.M., Yilmaz, U. and Colonna, P. (1999) "MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians", J. Clin. Oncol. 17, 730-734.
26. Schouten, H.C., Sanger, W.G., Weisenburger, D.D., Anderson, J. and Armitage, J.O. (1990) "Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group", Blood 75, 1841-1847.
27. Vose, J.M., Anderson, J.R., Bierman, P.J., Bast, M., Weisenburger, D., Chan, W.C., Bishop, M.R. and Armitage, J.O. (1994) "Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group", Semin. Hematol. 31, 4-8.
28. Velasquez, W.S., Cabanillas, F., Salvador, P., cLaughlin, P., Fridrik, M., Tucker, S., Jagannath, S., Hagemeister, F.B., Redman, J.R. and Swan, F. (1988) "Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP ", Blood 71, 117-122.
29. Fields, K.K., Zorsky, P.E., Hiemenz, J.W., Kronish, L.E. and Elfenbein, G.J. (1994) "Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity", J. Clin. Oncol. 12, 544-552.
30. Velasquez, W.S., McLaughlin, P., Tucker, S., Hagemeister, F.B., Swan, F., Rodriguez, M.A., Romaguera, J., Rubenstein, E. and Cabanillas, F. (1994) "ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study", J. Clin. Oncol. 12, 1169-1176.
31. Prokocimer, M., Modan, M., Rusoshansky, S., Bairey, O. and Shaklai, M. (1989) "ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma", Anticancer Res. 9, 1233-1235.
32. Salar, A., Sierra, J., Gandarillas, M., Caballero, M.D., Marin, J., Lahuerta, J.J., Garcia-Conde, J., Arranz, R., Leon, A., Zuazu, J., Garcia-Larana, J., Lopez-Guillermo, A., Sanz, M.A., Granena, A., Garcia, J.C. and Conde, E. (2001) "Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens", Bone Marrow Transplant. 27, 405-412.
33. Kessinger, A., Vose, J.M., Bierman, P.J., Bishop, M. and Armitage, J.O. (1993) "Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients", J. Hematother. 2, 361-362.
34. Armitage, J.O. (1990) "Bone marrow transplantation in the treatment of lymphoma", Curr. Opin. Oncol. 2, 843-848.
35. Cheson, B.D., Horning, S.J., Coiffier, B., Shipp, M.A., Fisher, R.I., Connors, J.M., Lister, T.A., Vose, J., Grillo-Lopez, A., Hagenbeek, A., Cabanillas, F., Klippensten, D., Hiddemann, W., Castellino, R., Harris, N.L., Armitage, J.O., Carter, W., Hoppe, R. and Canellos, G.P. (1999) "Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group", J. Clin. Oncol. 17, 1244.
36. Raine, L. and Fanger, H. (1981) "Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures", J Histochem. Cytochem. 29, 577-580.
37. Kaplan, E. and Meier, P. (1958) "Nonparametric estimation from incomplete observation", J. Am. Stat. Assoc. 53, 457-481.
38. Cox, J.D. and Stoffel, T.J. (1980) "Clinical versus pathologic stage I and II Hodgkin's disease", Oncology 37, 325-328.
39. Mittal, B.B. and Nalesnik, M. (1986) "Composite lymphoma (Hodgkin's and non-Hodgkin's) of the spleen in a previously untreated patient", Acta Haematol. 76, 29-32.
40. Rudiger, T., Gascoyne, R.D., Jaffe, E.S., de Jong, D., Delabie, J., De Wolf-Peeters, C., Poppema, S., Xerri, L., Gisselbrecht, C., Wiedenmann, S. and Muller-Hermelink, H.K. (2002) "Workshop on the relationship between nodular lymphocyte predominant Hodgkin'slymphoma and T cell/histiocyte-rich B cell lymphoma", Ann. Oncol. 13(Suppl. 1), 44-51.